Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

Kristina R. Chacko, Paul J. Gaglio

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

Original languageEnglish (US)
Pages (from-to)605-617
Number of pages13
JournalClinics in Liver Disease
Volume19
Issue number4
DOIs
StatePublished - Nov 1 2015

Fingerprint

Virus Replication
Hepacivirus
Antiviral Agents

Keywords

  • Direct-acting antiviral agents
  • NS5A inhibitors
  • Polymerase inhibitors
  • Protease inhibitors

ASJC Scopus subject areas

  • Hepatology

Cite this

Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses. / Chacko, Kristina R.; Gaglio, Paul J.

In: Clinics in Liver Disease, Vol. 19, No. 4, 01.11.2015, p. 605-617.

Research output: Contribution to journalArticle

@article{b8640f217a09489991b96592c653a9c6,
title = "Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.",
abstract = "This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.",
keywords = "Direct-acting antiviral agents, NS5A inhibitors, Polymerase inhibitors, Protease inhibitors",
author = "Chacko, {Kristina R.} and Gaglio, {Paul J.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.cld.2015.06.002",
language = "English (US)",
volume = "19",
pages = "605--617",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

AU - Chacko, Kristina R.

AU - Gaglio, Paul J.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

AB - This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

KW - Direct-acting antiviral agents

KW - NS5A inhibitors

KW - Polymerase inhibitors

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84943583020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943583020&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2015.06.002

DO - 10.1016/j.cld.2015.06.002

M3 - Article

VL - 19

SP - 605

EP - 617

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -